James V. Freeman

6.4k total citations · 1 hit paper
143 papers, 3.7k citations indexed

About

James V. Freeman is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, James V. Freeman has authored 143 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Cardiology and Cardiovascular Medicine, 18 papers in Economics and Econometrics and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in James V. Freeman's work include Atrial Fibrillation Management and Outcomes (99 papers), Cardiac Arrhythmias and Treatments (83 papers) and Cardiac pacing and defibrillation studies (32 papers). James V. Freeman is often cited by papers focused on Atrial Fibrillation Management and Outcomes (99 papers), Cardiac Arrhythmias and Treatments (83 papers) and Cardiac pacing and defibrillation studies (32 papers). James V. Freeman collaborates with scholars based in United States, Canada and Australia. James V. Freeman's co-authors include Jeptha P. Curtis, Alan S. Go, Paul J. Wang, Mark A. Hlatky, Jonathan P. Piccini, Gregg C. Fonarow, Eric D. Peterson, Joseph G. Akar, Kenneth W. Mahaffey and Mintu P. Turakhia and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

James V. Freeman

133 papers receiving 3.6k citations

Hit Papers

The NCDR Left Atrial Appendage Occlusion Registry 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The NCDR Left Atrial Appendage Occlusion Registry
    2020 224 citations James V. Freeman, Paul D. Varosy et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James V. Freeman United States 28 3.2k 386 376 375 288 143 3.7k
Dipak Kotecha United Kingdom 36 4.9k 1.5× 447 1.2× 396 1.1× 247 0.7× 474 1.6× 95 5.7k
Marco Proietti Italy 39 3.8k 1.2× 864 2.2× 314 0.8× 601 1.6× 732 2.5× 220 5.0k
Wesley T. O’Neal United States 33 3.0k 0.9× 223 0.6× 533 1.4× 118 0.3× 381 1.3× 158 3.9k
Jean‐Yves Le Heuzey France 32 4.5k 1.4× 604 1.6× 325 0.9× 328 0.9× 433 1.5× 88 5.0k
Laurent Fauchier France 44 5.9k 1.8× 781 2.0× 631 1.7× 280 0.7× 906 3.1× 322 6.7k
Michele Massimo Gulizia Italy 25 2.5k 0.8× 206 0.5× 255 0.7× 146 0.4× 237 0.8× 242 3.0k
Nikolaos Dagres Germany 36 4.3k 1.3× 268 0.7× 494 1.3× 157 0.4× 251 0.9× 239 5.0k
Ziad Hijazi Sweden 34 4.0k 1.3× 1.3k 3.4× 406 1.1× 159 0.4× 724 2.5× 89 4.8k
Raul D. Mitrani United States 23 2.5k 0.8× 81 0.2× 192 0.5× 152 0.4× 197 0.7× 85 3.0k
Roger M. Mills United States 40 3.2k 1.0× 316 0.8× 441 1.2× 76 0.2× 408 1.4× 143 4.4k

Countries citing papers authored by James V. Freeman

Since Specialization
Citations

This map shows the geographic impact of James V. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James V. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James V. Freeman more than expected).

Fields of papers citing papers by James V. Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James V. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James V. Freeman. The network helps show where James V. Freeman may publish in the future.

Co-authorship network of co-authors of James V. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of James V. Freeman. A scholar is included among the top collaborators of James V. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James V. Freeman. James V. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garg, Jalaj, Rajesh Kabra, Rakesh Gopinathannair, et al.. (2025). State of the Art in Left Atrial Appendage Occlusion. JACC. Clinical electrophysiology. 11(3). 602–641. 9 indexed citations
2.
Stendahl, John C., Sounok Sen, Michael Butzner, et al.. (2025). Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation. Journal of the American Heart Association. 14(17). e038755–e038755.
3.
Higgins, Angela, Sarah Zimmerman, Yongfei Wang, et al.. (2025). LONG-TERM OUTCOMES FOLLOWING LEFT ATRIAL APPENDAGE OCCLUSION IN MEDICARE BENEFICIARIES: OUTCOMES FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY. Journal of the American College of Cardiology. 85(12). 869–869. 1 indexed citations
4.
Sandhu, Amneet, Karl E. Minges, Sarah Zimmerman, et al.. (2025). Same‐Day Discharge After Catheter Ablation of Atrial Fibrillation in the United States. Journal of the American Heart Association. 14(9). e039190–e039190. 2 indexed citations
5.
Shah, Atman P., James V. Freeman, Mohamad Alkhouli, et al.. (2025). Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study. Cardiovascular revascularization medicine.
6.
Hu, Jiun‐Ruey, et al.. (2025). Healthcare Expenditure on Atrial Fibrillation in the United States. JACC Advances. 4(5). 101716–101716.
7.
Merkler, Alexander E., et al.. (2024). Ischemic Stroke and Reduced Left Ventricular Ejection Fraction: A Multidisciplinary Approach to Optimize Brain and Cardiac Health. Stroke. 55(6). 1720–1727. 4 indexed citations
8.
9.
Kapadia, Samir, Robert W. Yeh, Matthew J. Price, et al.. (2024). Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry. Circulation Cardiovascular Interventions. 17(9). 11 indexed citations
10.
Faridi, Kamil F., Sarah Zimmerman, Paul D. Varosy, et al.. (2024). Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion. Circulation Arrhythmia and Electrophysiology. 17(4). e012424–e012424. 2 indexed citations
11.
Saw, Jacqueline, David R. Holmes, João L. Cavalcante, et al.. (2023). SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure. Heart Rhythm. 20(5). e1–e16. 57 indexed citations
12.
Darden, Douglas, Muhammad Bilal Munir, Sarah Zimmerman, et al.. (2023). Frailty and associated outcomes in patients undergoing percutaneous left atrial appendage occlusion: findings from the NCDR LAAO registry. Journal of Interventional Cardiac Electrophysiology. 67(3). 625–635. 5 indexed citations
13.
Go, Alan S., Sana M. Al‐Khatib, Patrice Desvigne‐Nickens, et al.. (2023). Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Stroke. 54(3). 4 indexed citations
14.
Darden, Douglas, Omar M. Aldaas, Chengan Du, et al.. (2023). In-hospital complications associated with pulmonary vein isolation with adjunctive lesions: the NCDR AFib Ablation Registry. EP Europace. 25(5). 7 indexed citations
15.
Carlisle, Matthew A., Peter Shrader, Marat Fudim, et al.. (2022). Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation. Heart Rhythm O2. 3(6). 621–628. 3 indexed citations
16.
Daimee, Usama A., Yongfei Wang, Frederick A. Masoudi, et al.. (2022). Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry. Circulation Cardiovascular Quality and Outcomes. 15(8). e008418–e008418. 17 indexed citations
17.
Pareek, Manan, Avinainder Singh, Zaniar Ghazizadeh, et al.. (2021). Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry). The American Journal of Cardiology. 146. 99–106. 17 indexed citations
18.
Hsu, Jonathan C. & James V. Freeman. (2018). Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review. Clinical Pharmacology & Therapeutics. 104(2). 301–310. 24 indexed citations
19.
Freeman, James V., Jingrong Yang, Sue Hee Sung, Mark A. Hlatky, & Alan S. Go. (2013). Effectiveness and Safety of Digoxin Among Contemporary Adults With Incident Systolic Heart Failure. Circulation Cardiovascular Quality and Outcomes. 6(5). 525–533. 60 indexed citations
20.
Hadley, David, Frederick E. Dewey, James V. Freeman, Jonathan Myers, & Victor F. Froelicher. (2008). Prediction of Cardiovascular Death using a Novel Heart Rate Recovery Parameter. Medicine & Science in Sports & Exercise. 40(6). 1072–1079. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dipak Kotecha Breakdown of academic impact, for papers by Marco Proietti Breakdown of academic impact, for papers by Wesley T. O’Neal Breakdown of academic impact, for papers by Jean‐Yves Le Heuzey Breakdown of academic impact, for papers by Laurent Fauchier Breakdown of academic impact, for papers by Michele Massimo Gulizia Breakdown of academic impact, for papers by Nikolaos Dagres Breakdown of academic impact, for papers by Ziad Hijazi Breakdown of academic impact, for papers by Raul D. Mitrani Breakdown of academic impact, for papers by Roger M. Mills
Rankless by CCL
2026